(RTTNews) - argenx SE (ARGX), an immunology innovation company, on Thursday reported higher net income in the third quarter compared with the previous year.
Mostramos la idea principal publicamente. Crea una cuenta gratis para seguir leyendo el articulo completo, guardarlo, comentarlo y conectarlo con contexto de mercados y OSINT.